Titin Mutations Cardiomyopathy C2C12 Muscular dystrophy LMNA Myologie A-type lamins GNE Nuclear envelope Treatment COL6A1 Actionability Connective tissue Clinical trial Mouse Allele-specific silencing Dilated cardiomyopathy Cancer Rare neuromuscular diseases Becker muscular dystrophy COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders COVID-19 Muscle Cancer biomarkers Laminopathy Angiotensin-converting enzyme inhibitor Laminopathie CRISPR INPP5K C elegans Muscular dystrophy MD Dystrophine Angiotensin-converting enzyme inhibitors Lamin A/C Exome A-type lamin POPDC1 Laminopathies Diagnosis Neuromuscular diseases Maladies rares Actionable gene BVES Emerin Centronuclear myopathy CMTX Myopathy BiP Cardiology Therapy Maladies rares et orphelines Patient registry Next generation sequencing Errance diagnostique Autophagosome maturation Heart Duchenne muscular dystrophy Myopathies Joint laxity Skeletal muscle LMNA-related congenital muscular dystrophy Heart failure Regeneration CSF protein Dynamin 2 Muscle biopsy AAV VECTOR LMNA gene Myotubes Lamin A/C nuclei Gene therapy Calcium handling Hypermobile EDS Ehlers‐Danlos Syndrome Dystrophie musculaire Lamins COL1A1 Base de données FAIR LGMD Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS IPSC Adult SMA Rare diseases Lamin A/C LMNA gene Emery-Dreifuss muscular dystrophy Muscle MRI Biomarker Allele‐specific silencing therapy Butyrylcholinesterase Alternative splicing Cardiac conduction system Myogenesis Congenital muscular dystrophy RNA interference AAV Treatment delay Biological sciences Acetyltransferase Allele-specific silencing therapy